Skip to content

Efficacy and safety of Repetitive Transcranial Magnetic Stimulation (r-TMS) in ejaculation dysfunction

Efficacy and safety of Repetitive Transcranial Magnetic Stimulation (r-TMS) in ejaculation dysfunction

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081530
Enrollment
Unknown
Registered
2024-03-04
Start date
2022-10-01
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ejaculation disorders

Interventions

AE group 1:rTMS
AE group 2:Sham stimulation
PE group 1:rTMS
PE group 2:Sham stimulation

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Adults have a stable sexual life and sexual partner for at least 6 months; 2. Meet the diagnostic criteria for PE or DE (including AE);, 3. This happens every time you have sex since your first sexual intercourse. 4. No erectile dysfunction; 5. There is no clear history of drug use or known disease history that can cause ejaculation disorders.

Exclusion criteria

Exclusion criteria: (1) Patients with a history of epileptic seizures or drug abuse; (2) Patients with any history of serious medical illness, mental illness or neurological disease; (3) Irregular sexual life or without normal sexual partners.

Design outcomes

Primary

MeasureTime frame
IELT;HAMD;HAMA;PSQI;MSHQ-EjD;Functional magnetic resonance imaging, fMRI;

Secondary

MeasureTime frame
Edinburgh Handedness Inventory;5-HT ;

Countries

China

Contacts

Public ContactXiansheng Zhang

The First Affiliated Hospital of Anhui Medical University

xiansheng-zhang@163.com+86 135 1497 1898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026